Cargando…

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells

Follicular helper T cells (T(FH)) are critical for vaccine and infection elicitation of long-lived humoral immunity, but exaggerated T(FH) responses can promote autoimmunity and other pathologies. It is unfortunate that no clinical interventions exist for the selective depletion of follicular T cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reighard, Seth D., Cranert, Stacey A., Rangel, Kelly M., Ali, Ayad, Gyurova, Ivayla E., de la Cruz-Lynch, Arthur T., Tuazon, Jasmine A., Khodoun, Marat V., Kottyan, Leah C., Smith, David F., Brunner, Hermine I., Waggoner, Stephen N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455007/ https://www.ncbi.nlm.nih.gov/pubmed/32864635 http://dx.doi.org/10.1016/j.xcrm.2020.100003

Ejemplares similares

Roles of natural killer cells in antiviral immunity
por: Waggoner, Stephen N, et al.
Publicado: (2016)

The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection
por: Rajaram, Sanjeeth, et al.
Publicado: (2020)

Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection
por: Gyurova, Ivayla E., et al.
Publicado: (2019)

Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers
por: Rydyznski, Carolyn E., et al.
Publicado: (2018)

Genetic, Inflammatory, and Epithelial Cell Differentiation Factors Control Expression of Human Calpain-14
por: Miller, Daniel E., et al.
Publicado: (2019)

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
por: Hermanson, David L., et al.
Publicado: (2015)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Chimeric antigen receptor engineered natural killer cells for cancer therapy
por: Zhang, Yalan, et al.
Publicado: (2023)

Natural killer cells act as rheostats modulating antiviral T cells
por: Waggoner, Stephen N., et al.
Publicado: (2011)

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer
por: Obajdin, J., et al.
Publicado: (2020)

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
por: Potnis, Kunal C., et al.
Publicado: (2022)

Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1
por: Guo, Huaijian, et al.
Publicado: (2016)

Correction: Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1
por: Guo, Huaijian, et al.
Publicado: (2016)

Basophils Initiate IL-4 Production during a Memory T-dependent Response
por: Khodoun, Marat V., et al.
Publicado: (2004)

Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis
por: Cho, Fu-Nan, et al.
Publicado: (2014)

Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review)
por: Peng, Xiaobo, et al.
Publicado: (2021)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

New targets for the treatment of follicular lymphoma
por: Tageja, Nishant, et al.
Publicado: (2009)

Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
por: Bahmanyar, Maryam, et al.
Publicado: (2022)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells
por: Le, Hung, et al.
Publicado: (2022)

CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells
por: Yang, Chun-Lin, et al.
Publicado: (2019)

Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation
por: Goh, Ri-Young, et al.
Publicado: (2011)

Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017)

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
por: Poels, Renée, et al.
Publicado: (2021)

Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
por: Elahi, Reza, et al.
Publicado: (2021)

2141. Investigating a (Natural) Killer by Studying the Victims: Searching for Mechanisms to Selectively Inhibit NK-cell Immunosuppressive Function to Improve Vaccine Responses
por: Cox, Andrew, et al.
Publicado: (2022)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma
por: He, L, et al.
Publicado: (2016)

Generation of cellular immune memory and B-cell immunity are impaired by natural killer cells
por: Rydyznski, Carolyn, et al.
Publicado: (2015)

Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
por: Jan, Chia-Ing, et al.
Publicado: (2021)

Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
por: Burger, Michael C, et al.
Publicado: (2023)

Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus
por: Khodoun, Marat, et al.
Publicado: (2020)

Calreticulin surface presentation: a signal for natural killer cells to attack
por: Castellanos, Jasmine P., et al.
Publicado: (2023)

Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0q72dnfrld65ls14vb2tgsrup